热点聚焦

专题首页 » 热点聚焦

⇔ [APASL2011]Preventing Perinatal transmission of HBV 2011-02-25
⇔ [APASL2011]Tenofovir no resistance after 192 weeks 2011-02-25
⇔ [APASL2011]Regulating liver transplantation for the future 2011-02-25
⇔ [APASL2011]Liver Fibrosis therapies: Getting to the source of the problem 2011-02-25
⇔ [APASL2011]HCV Non responders triple therapy for Non responders. 2011-02-25
⇔ [APASL2011]HBsAg: Ultimate endpoint and ultimate predictor of response? 2011-02-25
⇔ [APASL2011]HBV Population patterns 2011-02-25
⇔ [APASL2011]Eating yourself to survival 2011-02-25
⇔ [APASL2011]What to do for people with HCC contraindicated for people unsuitable for surgery? 2011-02-25
⇔ [APASL2011]Hepatopulmonary Syndrome and Portopulmonary Hypertension: Modern Concepts of Pathogenesis 2011-02-23
⇔ [APASL2011]Recent Advances in Imaging Diagnosis and Staging of HCC 2011-02-23
⇔ [APASL2011]Large HCC and Downstaging - A Difficult But Challenging Task 2011-02-23
⇔ [APASL2011]Raising the Barrier to HCV Resistance 2011-02-23
⇔ [APASL2011]We Need More Globally Cohesive HBV Treatment Management Strategies 2011-02-23
⇔ [APASL2011]Refractory Cirrhotic Ascites， Hyponatremia and Acute Kidney Injury in Cirrhosis 2011-02-23
⇔ [APASL2011]Autoimmune liver diseases — from bench to bed-side 2011-02-23
⇔ [APASL2011]Stem Cells in Liver Carcinogenesis 2011-02-23
⇔ [APASL2011]Emerging trends in the Management of Viral Hepatitis 2011-02-23
⇔ [APASL2011]Management of anemia in HCV patients: Timing is everything 2011-02-23
⇔ [APASL2011]Management of Hepatitis B from Asia-Pacific and Western Region Perspective : We Are Seeking Common Ground 2011-02-23

首页 1 2 3 下一页尾页

热点聚焦

专题标签

学术领域

扫描二维码，用手机看今日话题